Cite
HARVARD Citation
Hohmann, E. et al. (n.d.). 19. The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III, a Placebo-Controlled Clinical Trial. Open forum infectious diseases. p. S13. [Online].